retatrutide phase 2 trial dose escalation schedule Dosing Schedule: Proven 2026 Guide Retatrutide Dosage Chart: 2mg to

While these results show an association, not proof of cause and effect, they provide converging real-world evidence that #GLP1 therapies may offer benefits in IBD beyond metabolic disease and support further prospective study

This overlap is not inherently dangerous, but it means you are effectively on a dual medication regimen during the transition, which can amplify side effects

These medications carry a boxed warning for medullary thyroid carcinoma and are contraindicated in patients with personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2

Many experience reduced stamina on these medications